Explanatory Power and Prognostic Implications of Factors Associated with Troponin Elevation in Acute Ischemic Stroke
- 문서 유형
- 연구출판물 · 학술지 논문
- 등재
- KCISCIEScopus
- 저널 순위
- JCR Q1Scopus Q1KCI Q1
- 저널
- JOURNAL OF STROKE25(1) · pp.141 · 2023
- 피인용
- Web of Science 11Scopus 13KCI 0
- FWCI (Scopus)
- 1.2
- JCR IF
- JCR 2022 8.2
- ISSN
- 2287-6391
저자
- 안성호제1저자Pusan Natl Univ, Sch Med, Res Inst Convergence Biomed Sci & Technol, Dept Neurol,Yangsan Hosp, Busan, South Korea
- Lee, Ji-SungUniv Ulsan, Clin Res Ctr, Asan Med Ctr, Coll Med, Seoul, South Korea
- 윤미숙Pusan Natl Univ, Sch Med, Res Inst Convergence Biomed Sci & Technol, Div Biostat,Yangsan Hosp, Busan, South Korea
- Han, Jung-HeeUniv Ulsan, Coll Med, Asan Med Ctr, Dept Neurol, Seoul, South Korea
- Kim, Soo -YoungUniv Ulsan, Coll Med, Asan Med Ctr, Dept Neurol, Seoul, South Korea
- Kim, Young-HakUniv Ulsan, Asan Med Ctr, Div Cardiol, Coll Med, Seoul, South Korea
- 이상현Pusan Natl Univ, Sch Med, Res Inst Convergence Biomed Sci & Technol, Div Cardiol,Yangsan Hosp, Pusan, South Korea
- 박민규Pusan Natl Univ, Sch Med, Res Inst Convergence Biomed Sci & Technol, Dept Neurol,Yangsan Hosp, Busan, South Korea
- 박경필Pusan Natl Univ, Sch Med, Res Inst Convergence Biomed Sci & Technol, Dept Neurol,Yangsan Hosp, Busan, South Korea
- Kang, Dong-WhaUniv Ulsan, Coll Med, Asan Med Ctr, Dept Neurol, Seoul, South Korea
- Kim, Jong S.Univ Ulsan, Gangneung Asan Hosp, Dept Neurol, Kangnung, South Korea
- Kwon, Sun U.교신저자Univ Ulsan, Coll Med, Asan Med Ctr, Dept Neurol, Seoul, South Korea
초록
Background and Purpose We investigated the impact of comorbidity burden on troponin elevation, with separate consideration of neurological conditions, in patients with acute ischemic stroke (AIS). Methods This prospective, observational cohort study consecutively enrolled patients with AIS for 2 years. Serum cardiac troponin I was repeatedly measured, and disease-related biomarkers were collected for diagnosis of preassigned comorbidities, including atrial fibrillation (AF), ischemic heart disease (IHD), myocardial hypertrophy (MH), heart failure (HF), renal insufficiency (RI), and active cancer. The severity of neurological deficits and insular cortical ischemic lesions were assessed as neurological conditions. Adjusted associations between these factors and troponin elevation were determined using a multivariate ordinal logistic regression model and area under the receiver operating characteristic curve (AUC). Cox proportional hazards model was used to determine the prognostic significance of comorbidity beyond neurological conditions. Results Among 1,092 patients (66.5±12.4 years, 63.3% male), 145 (13.3%) and 335 (30.7%) had elevated (≥0.040 ng/mL) and minimally-elevated (0.040–0.010 ng/mL) troponin, respectively. In the adjusted analysis, AF, MH, HF, RI, active cancer, and neurological deficits were associated with troponin elevation. The multivariate model with six comorbidities and two neurological conditions exhibited an AUC of 0.729 (95% confidence interval [CI], 0.698–0.759). In Cox regression, AF, IHD, and HF were associated with adverse cardio-cerebrovascular events, whereas HF and active cancer were associated with mortality. Conclusion Troponin elevation in patients with AIS can be explained by the burden of comorbidities in combination with neurological status, which explains the prognostic significance of troponin assay.
키워드
ComorbidityPrognosisStrokeTroponinHEALTH-CARE PROFESSIONALSRECOMMENDATIONSBIOMARKERSCARDIOLOGYMORTALITYSTATEMENTOUTCOMESATTACKRISK
식별자
- Scopus EID
- 2-s2.0-85148356517
- WoS UID
- 000933197800015
- KCI
- ART002927800



로그인
연구물 목록으로